These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 31338833)

  • 41. Anti-Correlation between the Dynamics of the Active Site Loop and C-Terminal Tail in Relation to the Homodimer Asymmetry of the Mouse Erythroid 5-Aminolevulinate Synthase.
    Na I; Catena D; Kong MJ; Ferreira GC; Uversky VN
    Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29958424
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of a novel heterozygous ALAS2 mutation in a young Chinese female with X-linked sideroblastic anemia.
    Qiu Y; Cai H; Cui L; Liu YX; Wang YN; Li J; Cao XX
    Ann Hematol; 2020 Feb; 99(2):371-373. PubMed ID: 31848684
    [No Abstract]   [Full Text] [Related]  

  • 43. Late-onset X-linked sideroblastic anemia. Missense mutations in the erythroid delta-aminolevulinate synthase (ALAS2) gene in two pyridoxine-responsive patients initially diagnosed with acquired refractory anemia and ringed sideroblasts.
    Cotter PD; May A; Fitzsimons EJ; Houston T; Woodcock BE; al-Sabah AI; Wong L; Bishop DF
    J Clin Invest; 1995 Oct; 96(4):2090-6. PubMed ID: 7560104
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Arg452 substitution of the erythroid-specific 5-aminolaevulinate synthase, a hot spot mutation in X-linked sideroblastic anaemia, does not itself affect enzyme activity.
    Furuyama K; Harigae H; Heller T; Hamel BC; Minder EI; Shimizu T; Kuribara T; Blijlevens N; Shibahara S; Sassa S
    Eur J Haematol; 2006 Jan; 76(1):33-41. PubMed ID: 16343269
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Luspatercept for the treatment of congenital sideroblastic anemia: Two case reports.
    Shao Y; He L; Ding S; Fu R
    Curr Res Transl Med; 2024 Mar; 72(1):103438. PubMed ID: 38244303
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Biology of sideroblastic anemia].
    Harigae H
    Rinsho Ketsueki; 2017; 58(4):347-352. PubMed ID: 28484165
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hereditary sideroblastic anemias: pathophysiology, diagnosis, and treatment.
    Camaschella C
    Semin Hematol; 2009 Oct; 46(4):371-7. PubMed ID: 19786205
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sideroblastic anaemia.
    May A; Fitzsimons E
    Baillieres Clin Haematol; 1994 Dec; 7(4):851-79. PubMed ID: 7881157
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Regulation and tissue-specific expression of δ-aminolevulinic acid synthases in non-syndromic sideroblastic anemias and porphyrias.
    Peoc'h K; Nicolas G; Schmitt C; Mirmiran A; Daher R; Lefebvre T; Gouya L; Karim Z; Puy H
    Mol Genet Metab; 2019 Nov; 128(3):190-197. PubMed ID: 30737140
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The molecular basis of the sideroblastic anemias.
    Fitzsimons EJ; May A
    Curr Opin Hematol; 1996 Mar; 3(2):167-72. PubMed ID: 9372069
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Disparate phenotypic expression of ALAS2 R452H (nt 1407 G --> A) in two brothers, one with severe sideroblastic anemia and iron overload, hepatic cirrhosis, and hepatocellular carcinoma.
    Barton JC; Lee PL
    Blood Cells Mol Dis; 2006; 36(3):342-6. PubMed ID: 16540354
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Recent progress in iron metabolism and iron-related anemia].
    Harigae H
    Rinsho Byori; 2010 Dec; 58(12):1211-8. PubMed ID: 21348241
    [TBL] [Abstract][Full Text] [Related]  

  • 53. X-linked Sideroblastic Anemia in a Malay Boy With ALAS2 S568G Mutation.
    Susanto TAK; Bhattacharyya R
    J Pediatr Hematol Oncol; 2017 Jul; 39(5):408-409. PubMed ID: 28644307
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comprehensive Genomic Analysis Identifies a Diverse Landscape of Sideroblastic and Nonsideroblastic Iron-Related Anemias with Novel and Pathogenic Variants in an Iron-Deficient Endemic Setting.
    Sharma P; Bhatia P; Singh M; Jamwal M; Pallavelangini S; Das R; Malhotra P; Attri SV; Ducamp S; Fleming MD; Trehan A
    J Mol Diagn; 2024 May; 26(5):430-444. PubMed ID: 38360212
    [TBL] [Abstract][Full Text] [Related]  

  • 55. SLC25A38 congenital sideroblastic anemia: Phenotypes and genotypes of 31 individuals from 24 families, including 11 novel mutations, and a review of the literature.
    Heeney MM; Berhe S; Campagna DR; Oved JH; Kurre P; Shaw PJ; Teo J; Shanap MA; Hassab HM; Glader BE; Shah S; Yoshimi A; Ameri A; Antin JH; Boudreaux J; Briones M; Dickerson KE; Fernandez CV; Farah R; Hasle H; Keel SB; Olson TS; Powers JM; Rose MJ; Shimamura A; Bottomley SS; Fleming MD
    Hum Mutat; 2021 Nov; 42(11):1367-1383. PubMed ID: 34298585
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The molecular biology and pyridoxine responsiveness of X-linked sideroblastic anaemia.
    May A; Bishop DF
    Haematologica; 1998 Jan; 83(1):56-70. PubMed ID: 9542324
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mutations in mitochondrial carrier family gene SLC25A38 cause nonsyndromic autosomal recessive congenital sideroblastic anemia.
    Guernsey DL; Jiang H; Campagna DR; Evans SC; Ferguson M; Kellogg MD; Lachance M; Matsuoka M; Nightingale M; Rideout A; Saint-Amant L; Schmidt PJ; Orr A; Bottomley SS; Fleming MD; Ludman M; Dyack S; Fernandez CV; Samuels ME
    Nat Genet; 2009 Jun; 41(6):651-3. PubMed ID: 19412178
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Microcytic anemia in a pregnant woman: beyond iron deficiency.
    Rollón N; Fernández-Jiménez MC; Moreno-Carralero MI; Murga-Fernández MJ; Morán-Jiménez MJ
    Int J Hematol; 2015 May; 101(5):514-9. PubMed ID: 25547425
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Study of Glycine and Folic Acid Supplementation to Ameliorate Transfusion Dependence in Congenital SLC25A38 Mutated Sideroblastic Anemia.
    LeBlanc MA; Bettle A; Berman JN; Price VE; Pambrun C; Yu Z; Tiller M; McMaster CR; Fernandez CV
    Pediatr Blood Cancer; 2016 Jul; 63(7):1307-9. PubMed ID: 27038157
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Congenital sideroblastic anemia model due to ALAS2 mutation is susceptible to ferroptosis.
    Ono K; Fujiwara T; Saito K; Nishizawa H; Takahashi N; Suzuki C; Ochi T; Kato H; Ishii Y; Onodera K; Ichikawa S; Fukuhara N; Onishi Y; Yokoyama H; Yamada R; Nakamura Y; Igarashi K; Harigae H
    Sci Rep; 2022 May; 12(1):9024. PubMed ID: 35637209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.